Why overall survival is still the gold standard end point
Why overall survival is still the gold standard end point
Haematology updates from SIOG 2020
Critical issues in drug and biomarker development and standardisation of assays
Geographic disparities in access to cancer clinical trials in India
Latest in non-small cell lung cancer pathology
The Burkitt lymphoma international prognostic index
Guidelines to ensure high quality palliative care
The use of PARP inhibitors in oncology from a palliative care perspective
Cyber knife radiation for prostate cancer
An overview of the London Global Cancer Week
OncoAlert Colloquium Day 5: Genitourinary tumours and social media
OncoAlert Colloquium Day 4: Gynae-oncology, lymphoma, sarcoma and melanoma